Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Storch Maria |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Haindl, M; Kock, U; Zeitelhofer-Adzemovic, M; Storch, MK; Fazekas, F; Hochmeister, S
Investigation of remyelination facilitating factors produced by astrocytes in an animal model of multiple sclerosis
MULT SCLER J. 2016; 22: 165-165.-32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS); SEP 14-17, 2016; London, ENGLAND.
[Poster]
Web of Science
Haindl, M; Köck, U; Zeitelhofer-Adzemovic, M; Storch, MK; Fazekas, F; Hochmeister, S
Investigation of remyelination facilitating factors produced by astrocytes in an animal model of Multiple Sclerosis.
32th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ; SEPT 14-17, 2016; London, UNITED KINGDOM. 2016.
[Poster]
Haindl, M; Köck, U; Zeitelhofer-Adzemovic, M; Storch, MK; Fazekas, F; Hochmeister, S
Evidence for remyelination facilitating functions of astrocytes in an animal model of MS
13. Jahrestagung der österreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-18, 2016; Innsbruck, AUSTRIA. 2016.
[Poster]
Hochmeister, S; Adzemovic-Zeitelhofer, M; Bauer, J; Weissert, R; Linington, C.; Fazekas, F;. Storch, MK; Seifert-Held, T
Evidence for diverse roles of Bone Morphogenetic Protein-6 (BMP-6) in different models of inflammatory demyelinating disease.
21th Annual Meeting of the European Charcot Foundation; NOV 28-30, 2013; Baveno, ITALY. 2013.
[Poster]
Pekar, T; Stojakovic, T; Haas, J; Simmet, NE; Scharnagl, H; Gattringer, T; Fazekas, F; Storch, MK; Seifert-Held, T
Plasma neutrophil gelatinase-associated lipocalin and functional outcome in ischemic stroke
J Neurol Sci. 2013; 333 Suppl 1: e171-e171.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA.
[Poster]
Seifert-Held, T; Barounig, A; Offenbacher, H; Storch, MK; Weger, M; Langner-Wegscheider, B; Fazekas, F
Susac's syndrome: Three cases with predominant branch retinal artery occlusion at first presentation
J Neurol Sci. 2013; 333 Suppl 1: e599-e600.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA.
[Poster]
Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Bocksrucker, C; Lampl, C; Storch, MK; Stojakovic, T; Fazekas, F
Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke
J Neurol Sci. 2013; 333 Suppl 1: e171-e172.-XXI World Congress of Neurology; SEP 21-26, 2013; Vienna, AUSTRIA.
[Poster]
Aboul-Enein, F; Rauschka, H; Mader,S; Künz, B; Lutterotti, A; Seifert, ; Khalil, M; Rommer, P; Leutmezer, F; Vass, K; Stepansky, R; Lang, W; Fertl, E; Schlager, T; Weiser, V; Koppi, S; Kraus, J; Assar, H; Eggers, C; Reisz, M; Komposch, M; Simschitz, P; Schnabl, P; Skrobal, A; Moser, A; Freimüller, M; Storch, MK; Reindl, M; Berger, T; Kristoferitsch, W
Erste Ergebnisse der ersten epidemiologischen Erfassung von Neuromyelitis optica (NMO) Patienten in Österreich.
10. Jahrestagung der Österreichischen Gesellschaft für Neurologie; MAR 14-17, 2012; Graz, AUSTRIA. 2012.
[Poster]
Fairless, R; Williams, SK; Hoffmann, DB; Stojic, A; Hochmeister, S; Schmitz, F; Storch, MK; Diem, R
Neurodegeneration in the retina precedes manifest experimental optic neuritis.
Multiple Sclerosis Journal. 2012; 18 (S4):147-148.-28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE.
[Poster]
FullText
Hochmeister, S; Pekar, T; Kitic, M; Storch, MK; Fazekas, F; Linington, C
Maternal neurofascin-specific autoantibodies have no long term effect on CNS development
Multiple Sclerosis Journal. 2012; 18(S4):124-125.-28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 10-13, 2012; Lyon, FRANCE.
[Poster]
FullText
Pekar, T; Stojakovic, T; Haas, J; Simmet, N; Scharnagl, H; Gattringer, T; Fazekas, F; Storch, M; Seifert-Held, T
Neutrophil gelatinase-associated lipocalin after acute ischemic stroke: relation to post-stroke infections and long-term outcome
neurologisch; Supplementum 1/2012. 2012; 91--10. Jahrestagung der österreichischen Gesellschaft für Neurologie; MAR 14 - 17, 2012; Graz, AUSTRIA.
[Poster]
Hochmeister, S; Engel, O; Storch, MK; Meisel, A
Minocycline and Ceftriaxone treatment in an animal model of focal cerebral ischemia
9. Jahrestagung der österreichischen Gesellschaft für Neurologie; MAR 16-19, 2011; Vienna, AUSTRIA. 2011.
[Poster]
Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK; Seifert-Held, T
Elevated plasma levels of Dickkopf-1 in acute ischemic stroke
Jatros Neurologie & Psychiatrie; Abstractband. 2011; 19(2):12--11. Neuroscience Wintermeeting; MAR 31 - APR 2; Kitzbühel, AUSTRIA.
[Poster]
Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, N; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK
Elevated plasma levels of Dickkopf-1 in acute ischemic stroke
neurologisch2011; Supplementum 1/2011: 73-73.-9. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 16-19, 2011; Vienna, AUSTRIA.
[Poster]
Seifert-Held, T; Pekar, T; Gattringer, T; Simmet, NE; Scharnagl, H; Stojakovic, T; Fazekas, F; Storch, MK
Elevated plasma levels of Dickkopf-1 in acute ischaemic stroke.
J NEUROL. 2011; 258: 176-176.-21st Meeting of the European Neurological Society (ENS); MAY 28-31, 2011; Lisbon, PORTUGAL.
[Poster]
Web of Science
Hochmeister, S; Pekar, T; Williams, SK; Fairless, R; Flockerzi, V; Freichel, M; Cavalie, C; Diem,R; Storch, MK
Aggravation of Autoimmune mediated Inflammation and Neurodegeneration in Calcium Channel Beta 3 knockout mice.
8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB 24-27, 2010; Linz, AUSTRIA. 2010.
[Poster]
Hochmeister, S; Seifert-Held, T; Bauer, J; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Evidence for diverse roles of bone morphogenetic protein-6 in different models of inflammatory demyelinating disease.
Multiple Sclerosis2010; 16 (Suppl.)(10):S74-S75.-26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Annual Conference of Rehabilitation in MS (RIMS); OCT 13-16, 2010; Gothenburg, SWEDEN.
[Poster]
Mader; S; Lutterotti, A; Aboul-Enein, F; Di Pauli, F; Jarius, S; Storch, MK; Berger, T; Kristoferitsch, W; Reindl, M
Austrian NMO Study Group: Patterns of antibody binding to aquaporin-4 isoforms in Neuromyelitis Optica
8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB, 24-27; Linz, Austria. 2010.
[Poster]
Pekar, T; Fürbaß, A; Simmet, NE; Quehenberger, F; Ropele, S; Fazekas, F; Storch, MK; Seifert-Held, T
Serum markers for prognosis in ischemic stroke
joint ZMF & doctoral days; NOV 5-6, 2010; Graz, AUSTRIA. 2010.
[Poster]
Seifert-Held, T; Pekar, T; Galler, V; Simmet, N; Quehenberger, F; Ropele, S; Fazekas, F; Storch, M
Prognostische Serum-Marker nach ischämischem Schlaganfall - Eine Pilot-Studie
13. Jahrestagung der Österreichischen Gesellschaft für Schlaganfallforschung (ÖGSF); Jan 15-16, 2010; Klagenfurt, Austria. 2010.
[Oral Communication]
Seifert-Held, T; Pekar, T; Galler, V; Simmet, N; Quehenberger, F; Ropele, S; Fazekas F; Storch, M
Prognostische Serum-Marker nach ischämischem Schlaganfall - eine Pilot-Studie
8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB, 24-27; Linz, Austria. 2010.
[Poster]
Storch, M
Einfluss von DMTs auf Entzündung, Neuroprotektion und Repair im ZNS
Neurologisch-Rheumatologisches Symposium; März 20, 2010; Graz, AUSTRIA. 2010.
[Oral Communication]
Storch, M
Fallseminar Clinically Isolated Syndrome
8. Jahrestagung der Österreichischen Gesellschaft für Neurologie; FEB, 24-27; Linz, Austria. 2010.
[Oral Communication]
Storch, M
Wirkungskonzepte der neueren MS Therapien
MS Akademie der Österreichischen Gesellschaft für Neurologie; OKT 8-9, 2010; Altlengbach. 2010.
[Oral Communication]
Wallner-Blazek, M; Khalil, M; Petrovic, K; Hochmeister, S; Seifert-Held, T; Enzinger, C; Storch, M; Schmidt, R; Fazekas, F; Fuchs, S
Klassifikation und Prognose der Multiplen Sklerose und verwandter Krankheitsbilder.
MUG-Forschungsfeld Neurowissenschaften; JUN 10, 2010; Graz, AUSTRIA. 2010.
[Oral Communication]
Hochmeister, S; Seifert- Held, T; Romauch, M; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Remyelination in experimental autoimmune encephalomyelitis is not impaired by extensive glial scar formation.
neurologisch 2009 Sonderausgabe2009; 21-21.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, Austria.
[Oral Communication]
Hochmeister, S; Seifert-Held, T; Romauch, M; Weissert, R; Linington, C; Fazekas, F; Storch, M
Remyelination in experimental autoimmune encephalomyelitis is not impaired by extensive glial scar formation
MULT SCLER. 2009; 15(9):S180-S181.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9-12, 2009; Düsseldorf, GERMANY.
[Poster]
Web of Science
Hochmeister, S; Seifert-Held, T; Romauch, M; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Extensive glial scar formation does not impede remyelination in Autoimmune Encephalomyelitis
neurologisch2009; Sonderausgabe: 13-13.-7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA.
[Poster]
Mader, S; Kuenz, B; Lutterotti, A; Rainer, C; Aboul-Enein, F; Storch, M; Berger, T; Kristoferitsch, W; Reindl, M
Antibodies to aquaporin-4 in neuromyelitis optica - experiences of the Austrian NMO study group
MULT SCLER. 2009; 15(9):S151-S152.-ECTRIMS; SEP 9-12; Düsseldorf, GERMANY.
[Poster]
Web of Science
Seifert- Held, T; Hochmeister, S; Bauer, J; Weissert, R; Linington, C; Fazekas, F; Storch, MK
The differential expression of BMP-6 indicates a dual role of this embryonic morphogen in lesion pathogenesis in certain models of inflammatory demyelination.
neurologisch2009; Sonderausgabe: 18-19.-7. Jahrestagung der österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA.
[Poster]
Seifert-Held, T; Hochmeister, S; Bauer, J; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Bone morphogenetic proteins (BMPs) play a dual role in lesion pathogenesis in inflammatory demyelinating disease
neurologisch 2009 Sonderausgabe 2009; 20-20.-10. Austrian Neuroscience Wintermeeting; MAR 4-7, 2009; Kitzbühel, Austria.
[Oral Communication]
Storch, M
Immunpathologie der Multiplen Sklerose
Fortschritte bei Multipler Sklerose / Fortbildungsveranstaltung der Wiener Ärztekammer; JAN 17, 2009; Vienna, AUSTRIA. 2009.
[Oral Communication]
Storch, M
Immunpathogenese der Multiplen Sklerose
Facharztausbildungsseminar für Neurologie; NOV 5-7; Graz, AUSTRIA. 2009.
[Oral Communication]
Storch, M
Zur Pathophysiologie der MS: State of the Art
8. MS-Herbstsymposium Vorarlberg; DEC 12; Rankweil, AUSTRIA. 2009.
[Oral Communication]
Storch, M
Update Tysabri
Tysabri. 4. Wiener Netzwerktreffen - Langzeitdaten, Sicherheitsaspekte; NOV 26; Wien, AUSTRIA. 2009.
[Oral Communication]
Storch, M
Vaskulitiden
Facharztausbildungsseminar für Neurologie; NOV 5-7; Graz, AUSTRIA. 2009.
[Oral Communication]
Storch, M
Gegenwärtige und hinkünftige Therapien der MS
8. MS-Herbstsymposium Vorarlberg; NOV 26; Rankweil, AUSTRIA. 2009.
[Oral Communication]
Storch, M; Archelos, J
Neuroimmunologie und Immuntherapie (Programmkoordination)
Facharztausbildungsseminar der Österreichischen Gesellschaft für Neurologie (ÖGN); NOV 5-7, 2009; Graz, AUSTRIA. 2009.
Storch, MK
Neuroprotektion und neue Therapien in der MS.
Fortbildung KH Wiener Neustadt; 2009.
[Oral Communication]
Storch, MK
Mechanismen der Gewebeschädigung und Reparatur bei MS.
Fortbildung, Konventhospital BHB Linz,; Okt 1, 2009; Linz, Austria. 2009.
[Oral Communication]
Storch, MK
Zukünftige MS-Therapien.
7. Jahrestagung der Österreichischen Gesellschaft für Neurologie und Jahrestagung der Österreichischen Gesellschaft für Neurorehabilitation; MAR 25-28, 2009; Villach, AUSTRIA. 2009.
[Oral Communication]
Storch, MK;
Mechanisman der Gewebeschädigung und Reparatur bei MS.
Fortbildung Konventhospital BHB Linz; Okt 1, 2009; Linz, Austria. 2009.
[Oral Communication]
Williams, SK; Fairless, R; Hochmeister, S; Flockerzi, V; Freichel, M; Storch, M; Cavalie, A; Diem, R
Calcium channel beta 3 subunit knock-out mice are more susceptible to neurodegeneration during experimental autoimmune encephalomyelitis
MULT SCLER. 2009; 15(9):S62-S63.-25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 9-12, 2009; Düsseldorf, GERMANY.
[Poster]
Web of Science
Hochmeister, S; Romauch M; Seifert T; Bauer J; Weissert R; Linington C; Hartung HP; Fazekas F; Storch MK
Re-expression of the adhesion molecule N-Cadherin in the lesions of experimental autoimmune encephalomyelitis implicates a role in remyelination
. 2008; 255(2): 113-113.
[Poster]
Web of Science
Hochmeister, S; Seifert, T; Romauch, M; Bauer, J; Linington, C; Weissert, R; Hartung, HP; Fazekas, F; Storch, MK
Expression Pattern of N-Cadherin in Autoimmune Encephalomyelitis Implicates a Role in Remyelination
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008.
[Poster]
Kristoferitsch, W; Storch, M
Innovation von Etabliertem - Etablieren von Innovation: MS Therapie 2008 (Vorsitz)
6. Jahrestagung der Österreichischen Gesellschaft für Neurologie, (ÖGN); FEB 6-9, 2008; Innsbruck, AUSTRIA. 2008.
Storch, M
Mechanismen der Gewebeschädigung und Reparatur bei MS
; NOV 4, 2008; Vienna, AUSTRIA. 2008.
[Oral Communication]
Storch, M
MS-Mechanismen der Gewebeschädigungen und Repairmöglichkeiten
Sanofi-Aventis Vortrag; NOV 27, 2008; Vienna, AUSTRIA. 2008.
[Oral Communication]
Storch, M
Immunpathologie und Mechanismen der Gewebsschädigung bei MS: Grundlagen der Pathophysiologie und Repairmöglichkeiten
MS Akademie der Österreichischen Gesellschaft für Neurologie; OCT 17-18, 2008; Mondsee, AUSTRIA. 2008.
[Oral Communication]
Storch, M
Die natürlichen Repair-Mechanismen reichen aus (contra)
2-Länder-Symposium; MAR 7-9, 2008; Innsbruck, AUSTRIA. 2008.
[Oral Communication]
Berer, K; Storch, M; Mather, I; Linington, C
Regulation through mimicry: The autologous milk protein butyrophilin determines susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis
CLIN IMMUNOL. 2007; 123: S11-S11.-Federation of Clinical Immunology Societies (FOCIS); JUN 7-11, 2007; San Diego, USA.
Doi: 10.1016/j.clim.2007.03.201
[Oral Communication]
Web of Science
FullText
FullText_MUG
Berer, K; Storch, MK; Mather, I; Linington, C
Breast is best: the autologous milk protein butyrophilin (BTN) induces a regulatory T cell response that cross-reacts with myelin oligodendrocyte glycoprotein (MOG)
IMMUNOLOGY. 2007; 120: 20-20.-British Society of Immunology (BSI) Congress; FEB 20-23, 2007; Glasgow, United Kindgom.
[Oral Communication]
Web of Science
Hochmeister, S; Romauch, M; Seifert, T; Bauer, J; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Re-expression of the adhesion molecule N-cadherin in the lesions of experimental autoimmune encephalomyelitis
MULT SCLER. 2007; 13: S260-S260.-23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); OCT 11-14, 2007; Prague, CZECH REPUBLIC.
[Poster]
Web of Science
Hochmeister, S; Romauch, M; Seifert,T; Bauer, J; Weissert, R; Linington,C; Hartung, HP; Fazekas, F; Storch, MK
The adhesion molecule N- Cadherin is reexpressed in the lesions of experimental autoimmune encephalomyelitis.
Symposium of the European Charcot Foundation; NOV 29- DEC 1, 2007; Fiuggi, Italy. 2007.
[Poster]
Linington, C; Mathey, E; Derfuss, T; Rasband, M; Storch, M; Hohlfeld, R; Meinl, E
Neurofascin-specific autoantibodies mediate axonal injury in inflammatory demyelinating diseases of the central nervous system
CLIN IMMUNOL. 2007; 123: S146-S146.-Federation of Clinical Immunology Societies (FOCIS); JUN 7-11, 2007; San Diego, USA.
Doi: 10.1016/j.clim.2007.03.052
[Oral Communication]
Web of Science
FullText
FullText_MUG
Mathey, EK; Derfuss, T; Storch, MK; Williams, KR; Hales, K; Wooley, D; Al-Hayani, A; Davies, S; Velhin, S; Rasband, M; Hohfeld, R; Meinl, E; Linington, C
Neurofascin: a target for antibody-mediated axonal injury in MS
IMMUNOLOGY. 2007; 120: 85-86.-British Society of Immunology (BSI) Congress; FEB 20-23, 2007; Glasgow, UNITED KINGDOM.
[Oral Communication]
Web of Science
Balatoni, B; Storch, MK; Weissert, R; Foster, CA
Oral fingolimod maintains and restores neuronal function in demyelinating models of multiple sclerosis, as assessed by somatosensory and visual evoked potentials
MULT SCLER. 2006; 12: S227-S227.-ECTRIMS; SEP 27-30, 2006; Madrid, Spain.
[Poster]
Web of Science
Mathey, EK; Williams, KR; Storch, MK; Linington, C
Antigen confirmation contributes to lesion distribution and clinical signs in relapsing remitting MOG-induced EAE
J NEUROIMMUNOL. 2006; 178: 159-159.-8th International Congress of Neuroimmunology; OCT 15-19, 2006; Nagoya, Japan.
[Poster]
Web of Science
Seifert, T; Bauer, J; Fazekas, F; Storch, MK
Expression of the embryonic morphogen BMP-6 is recapitulated in the lesions of experimental autoimmune encephalomyelitis
-4. Jahrestagung der Österreichischen Gesellschaft für Neurologie (ÖGN); MAR 15-18, 2006; Vienna, Austria.
[Oral Communication]
Seifert, T; Bauer, J; Weissert, R; Linington, C; Fazekas, F; Storch, MK
Re-expression of the embryonic morphogen BMP-6 in the lesions of experimental autoimmune encephalomyelitis
MULT SCLER. 12: S140-S140.-22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); SEP 27-30, 2006; Madrid, Spain.
[Poster]
Web of Science
Storch, MK; Weissert, R; Brok, HPM; Linington, C; Olsson, T; Hart, BA; Lassmann, H; Bauer, J
Cortical demyelination in models of autoimmune encephalomyelitis depends on MHC genes and demyelinating antibodies
J NEUROL. 2006; 253: 9-9.-16th Meeting of the European Neurological Society (ENS); MAY 27-31, 2006; Lausanne, SWITZERLAND.
[Poster]
Web of Science
Weissert, R; Albert, M; Ayturan, M; Olsson, T; Lassmann, H; Storch, MK
An animal model for cortical pathology of multiple sclerosis
MULT SCLER. 2006; 12: S8-S8.-ECTRIMS; SEP 27-30, 2006; Madrid, Spain.
[Oral Communication]
Web of Science
Balatoni, B; Storch, MK; Swoboda, EM; Koziel, A; Schonborn, V; Weissert, R; Foster, CA
Neuropathology in MOG-induced EAE correlates with complete prevention of electrophysiological changes and clinical symptoms following oral FTY720 treatment
MULT SCLER 2005 11: S44-S45.
Web of Science
Seifert, T; Bauer, J; Weissert, R; Fazekas, F; Storch, M
Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis
European Charcot Foundation Symposium; NOV 17-19, 2005; Lisbon, PORTUGAL. 2005.
[Poster]
Seifert, T; Enzinger, C; Ropele, S; Storch, M; Strasser-Fuchs, S; Fazekas, F
Relapsing acute transverse myelitis: a specific entity
European Charcot Foundation Symposium; NOV 17-19, 2005; Lisbon, PORTUGAL. 2005.
[Poster]
Storch, MK; Rausch, M; Hiestand, P; Balatoni, B; Foster, CA
FTY720 not only prevents EAE onset, as assessed by MRI, but also reverses established neurological deficits and extensive demyelination
MULT SCLER 2005 11: S45-S45.
Web of Science
Seifert, T; Bauer, J; Weissert, B; Fazekas, F; Storch, MK
Expression of sonic hedgehog during lesion evolution in autoimmune encephalomyelitis
MULT SCLER. 10: S197-S197.-20th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple- Sclerosis/9th Annual Meeting of Rehabilitation in MS; OCT 06-09, 2004; Vienna, AUSTRIA.
Web of Science
Seifert, T; Bauer, J; Weissert, R; Fazekas, F; Storch, MK
Expression of sonic hedgehog during lesion evolution in autoimmune encephalomyelitis
7th International Congress of the International Society of Neuroimmunology; SEP 28 - OCT 2, 2004; Venice, ITALY. 2004.
[Poster]
Seifert, T; Bauer, J; Weisssert, R; Fazekas, F; Storch, MK
Expression of sonic hedgehog during lesion evolution in autoimmune encephalomyelitis
J NEUROIMMUNOL 2004 154: 56-56.
Web of Science
Seifert T, Storch MK, Enzinger C, Niederkorn K, Fazekas F.
Clinical presentation and aetiology of lacunar infarction identified by Diffusion-Weighted Magnetic Resonance Imaging.
Neurology 2004;62(7/S5):A138.2004; -56th Annual Meeting of the American Academy of Neurology; April 24-May 1; San Francisco, California.
[Poster]
Storch, MK; Weissert, R; Stefferl, A; Birnbacher, R; Wallstrom, E; Dahlman, I; Linington, C; Olsson, T; Lassmann, H
MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis (EAE) determine the extent of axonal injury
GLIA 2002 S85: P334-P334.
Web of Science
Weissert, R; de Graaf, K; Storch, M; Linington, C; Lassmann, H; Olsson, T
MHC-peptide requirements for myelin oligodendrocyte glycoprotein immunogenicity and pathogenicity
FASEB J 2000 14: A1158-A1158.
Web of Science
Bittner, RE; Anderson, LVB; Burkhardt, E; Bashir, R; Vafiadaki, E; Ivanova, S; Maerk, I; Hoeger, H; Jung, M; Storch, M; Lassmann, H; Moss, JA; Davison, K; Harrison, R; Bushby, KMD; Reis, A
Redesignation of the SJL mouse (SJL-dysf) as a model for human dysferlin-deficient muscle disorders.
AMER J HUM GENET 1999 65: A33-A33.
Web of Science
Storch, MK; Stefferj, A; Weissert, R; Wallstrom, E; Olsson, T; Linington, C; Lassmann, H
MOG: a target autoantigen inducing multiple sclerosis-like lesions
BRAIN PATHOL 1997 7: 1196-1196.
Web of Science
Stefferl, A; Storch, M; Lassmann, H; Holsboer, F; Wekerle, H; Linington, C; Luheshi, GN
Myelin oligodendrocyte glycoprotein (MOG) induces chronic relapsing experimental allergic encephalomyelitis (CR-EAE) in the DA rat
BRIT J PHARMACOL 1996 117: P188-P188.
Web of Science